PAMPA permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone

Pharmacokinetics and Metabolism Division, Central Drug Research Institute, Lucknow-226001, Uttar Pradesh, India.
Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association (Impact Factor: 2.9). 05/2011; 49(5):1056-62. DOI: 10.1016/j.fct.2011.01.012
Source: PubMed


Formononetin (FMN) is a methoxylated isoflavone which is the major constituent in red clover and in commercially available extracts of this plant. In this study, we investigated the parallel artificial membrane permeability assay (PAMPA) permeability, protein binding, blood uptake characteristics, pharmacokinetics and metabolism of FMN. The permeability study samples were analyzed by HPLC-PDA method; whereas the pharmacokinetic study, protein binding and whole blood partitioning samples were analyzed by LC-MS/MS method. The PAMPA permeability of FMN was found to be high at pH 4.0 and 7.0. Plasma protein binding of FMN was found to be 93.61±0.44% and 96.14±0.15% at the tested concentration of 50 and 150 ng/mL, respectively. FMN reached equilibrium fast between red blood cells (RBCs) and plasma, and the partition coefficients between RBCs and plasma (K(RBC/PL)) were independent of the initial rat blood concentrations of FMN. The bioavailability of unchanged/free FMN was found to be poor, i.e. approximately 3%. FMN was found to have a high clearance (5.13 L/h/kg) and a large apparent volume of distribution (14.16L/kg). Circulating conjugates (glucuronides/sulfates) of FMN and daidzein (DZN) were quantified using enzymatic hydrolysis of plasma samples. The levels of isoflavone glucuronides/sulfates were found to be much greater than that of the corresponding aglycones.

Download full-text


Available from: Muhammad Wahajuddin,

Click to see the full-text of:

Article: PAMPA permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone

0 B

See full-text
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Supervisor's supporting comments Wahajuddin has shown strong enthusiasm with equal intensity of hard work in bioanalytical research since the day he joined as a scientist in this department. His intrinsic learning abilities made him acquire deep knowledge in the area of bioanalysis and he quickly became competent in conducting regulatory/exploratory studies in pharmacokinetics, biopharmaceutics and drug metabolism - harnessing the strengths of bioanalysis. Due to his skills and knowledge in advanced pharmaceutical analysis tools and techniques, he has also been given the responsibility to work as course coordinator for MS (Pharm.) Pharmaceutics at the newly established National Institute of Pharmaceutical Education and Research, which is an institute of national importance under the aegis of the Ministry of Chemicals and Fertilizers, Government of India. Through our Young Knowledge Promotion Initiative and Young Leadership Promotion Initiative, Wahajuddin was given the responsibility of being the corresponding author and first co-author in the majority of papers that have been published by our group, since he was instrumental in generating ideas, planning and executing the studies, compiling and analyzing the data and in writing and communicating the manuscripts. This enabled him to publish very good work in journals such as the Journal of Chromatography B, the Journal of Separation Science, Food & Chemical Toxicology, the Journal of Nutritional Biochemistry and Menopause within a very short period. Many other manuscripts are at various stages of communication and publication. His contribution also resulted in filing a patent application from the Central Drug Research Institute in 2007 (patent No.: #0081NF2007). He has also presented his work at many international conferences, symposia and seminars. He recently presented his work at the International Pharmaceutical Federation Pharmaceutical Science World Congress 2010 in association with American Association of Pharmaceutical Scientists Annual Exposition 2010 held on 14-18 November 2010 in New Orleans, USA. I am sure that he will achieve even greater feats in times to come and strongly recommend his candidature for Bioanalysis: Young Investigator 2011.
    Bioanalysis 04/2011; 3(8):839-41. DOI:10.4155/bio.11.70 · 3.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the development of drug discovery, more and more candidate compounds need to be studied. Methods that can screen compound rapidly received significant attention. Parallel artificial membrane permeability assay (PAMPA) as a powerful tool has been applied to drug studies. It uses an artificial lipid membrane to mimic the barrier for drug permeability studies. This article introduces the establishment and characteristics of PAMPA, as well as its applications in screening compounds. It can be used as models (e.g. predicting the ability of compound in gastro-intestinal absorption, blood-brain barrier transportation and skin penetration) by changing the component of artificial lipid membrane. PAMPA has advantages in high throughput selection of valuable compound with low cost, versatile, low dose, and good reproducibility.
    Yao xue xue bao = Acta pharmaceutica Sinica 08/2011; 46(8):890-5.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Parallel artificial membrane permeability assay (PAMPA) has been successfully applied by pharmaceutical industries as high-throughput technique capable of screening compounds for passive oral absorption. Herein, the possible applicability of this assay to predict simultaneously biodistribution parameters such as plasma protein binding (PPB) and apparent volume of distribution (VD) was investigated for the first time. Apparent permeability (P(app) ) of 18 reference drugs was determined by nine PAMPA conditions and compared with the corresponding intestinal absorption fraction (Fa), PPB, and VD in humans. In all the models, P(app) was not correlated with VD; however, it was correlated with Fa and PPB. In these cases, the best correlations (r ≥ 0.8953) were found when using a membrane of 2% of l-α-phosphatidylcholine, at pH 6.5/7.4 for donor/acceptor compartments. Under these conditions, good correlation with traditional PAMPA (r = 0.9633) and Caco-2 models (r = 0.9246) were also achieved. This method correctly predicted compounds' permeability and was robust enough to distinguish compounds with high Fa (P(app) ≥ 1.1 × 10(-6) cm/s) and PPB (P(app) ≥ 1.0 × 10(-5) cm/s), with no false positives or negatives recorded. In addition, ultrafiltration method was used to determine the PPB of 10 tested derivatives of dibenz[b,f]azepine-5-carboxamide, which were also assessed through the new PAMPA model developed herein, and equal classifications were achieved.
    Journal of Pharmaceutical Sciences 02/2012; 101(2):530-40. DOI:10.1002/jps.22796 · 2.59 Impact Factor
Show more